BIOTECHNOLOGY AND BIOENGINEERING, published by Wiley, is a leading journal in the domains of applied microbiology, biotechnology, and bioengineering. With an ISSN of 0006-3592 and E-ISSN of 1097-0290, this journal has established itself as an essential resource for researchers, professionals, and students aiming to advance their knowledge and stay updated on cutting-edge innovations and methodologies in biotechnology. The journal has a commendable impact factor, and it is ranked in the second quartile (Q2) across multiple categories for 2023. This positions it favorably among its peers, underscoring its significance in the scientific community; for example, it ranks 23rd out of 127 in the field of Applied Microbiology and Biotechnology. As a hub of critical research findings and technological advancements, BIOTECHNOLOGY AND BIOENGINEERING invites contributions that push the boundaries of biotechnological applications, fostering a deeper understanding and development of sustainable solutions to current global challenges.

ENGINEERING IN LIFE SCIENCES, published by Wiley, is a pivotal journal for professionals, researchers, and students dedicated to advancing the interdisciplinary fields of bioengineering, biotechnology, and environmental engineering. With an ISSN of 1618-0240 and an E-ISSN of 1618-2863, this journal has established itself as a reputable platform for disseminating innovative research findings and breakthroughs in engineering applications within the life sciences. Currently holding a prestigious Q2 ranking in multiple categories, including bioengineering and environmental engineering, it reflects a strong commitment to high-quality, impactful research (Scopus ranks: Environmental Science - Rank #61/197, Biochemistry, Genetics and Molecular Biology - Rank #112/311). The journal spans contributions from 2004 to 2024, ensuring a comprehensive archiving of evolving scientific discourse. Although it does not currently offer open access, its curated articles are accessible through institutional and single-article purchases, providing valuable insights and updates for the academic community. Join us in shaping the future of engineering within life sciences and stay informed on critical advancements that are driving innovation across multiple disciplines.

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT is a leading open access journal published by TAYLOR & FRANCIS LTD from the United Kingdom, dedicated to advancing the field of biotechnology since its inception in 1990. Committed to disseminating high-quality research, the journal has transitioned to open access since 2014, enhancing its accessibility for researchers, professionals, and students alike. With a notable impact in the field, it is categorized in the Q3 quartile for Biotechnology as of 2023 and ranks #193 out of 311 in the Scopus categories for Biochemistry, Genetics, and Molecular Biology. The journal aims to cover a diverse range of topics related to both biotechnological advancements and the equipment that supports them, thus fostering innovative research and practical applications in the biotechnology sector. With an evolving scope that reflects the dynamic nature of biological research, BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT plays a crucial role in bridging the gap between laboratory studies and real-world applications, making it an essential resource for anyone involved in biotechnology research.

Frontiers in Bioengineering and Biotechnology, published by FRONTIERS MEDIA SA in Switzerland, stands as a leading platform for innovative research and developments in the fields of bioengineering and biotechnology. Since its inception in 2013, this Open Access journal has garnered significant recognition, reflected in its impressive category rankings: Q1 in Biomedical Engineering and Q2 in Bioengineering, Biotechnology, and Histology for 2023. With a focus on fostering collaboration and knowledge sharing, it aims to provide researchers, professionals, and students with access to pioneering studies that push the boundaries of science and technology. The journal, which is indexed in prominent databases, boasts high visibility and impact, evidenced by its impressive rankings across various categories in Scopus. As it continues to converge from 2013 to 2024, Frontiers in Bioengineering and Biotechnology is dedicated to shaping the discourse in its field and promoting advancements that have the potential to transform healthcare and environmental sustainability.

NATURE BIOTECHNOLOGY, an esteemed journal published by NATURE PORTFOLIO, stands at the forefront of innovation in biotechnological research since its inception in 1989. With an impressive impact factor reflecting its preeminent status—ranked in the Q1 quartile across multiple categories including Applied Microbiology, Bioengineering, Biomedical Engineering, Biotechnology, and Molecular Medicine—this journal is a pivotal resource for researchers and professionals aiming to advance the boundaries of biotechnology. The journal is highly regarded, boasting Scopus rankings in the 99th percentile within its categories. NATURE BIOTECHNOLOGY provides a platform for disseminating cutting-edge findings, with open access options that enhance the visibility and accessibility of its content to a global audience. The scope of the journal encapsulates a diverse range of topics from genetic engineering to pharmaceutical developments, ensuring comprehensive coverage of emerging biotechnological advances. As the field continues to evolve, NATURE BIOTECHNOLOGY remains committed to publishing groundbreaking research that shapes the future of science and industry.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.